Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global health concern. The development of vaccines with high immunogenicity and safety is crucial for controlling the global COVID-19 pandemic and preventing furth...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Thi Nhu Mai, May, Bruce Pearson, Ung, Trong Thuan, Nguyen, Mai Khoi, Nguyen, Thi Thuy Trang, Dinh, Van Long, Doan, Chinh Chung, Tran, The Vinh, Khong, Hiep, Nguyen, Thi Thanh Truc, Hua, Hoang Quoc Huy, Nguyen, Viet Anh, Ha, Tan Phat, Phan, Dang Luu, Nguyen, Truong An, Bui, Thi Ngoc, Tu, Tieu My, Nguyen, Thi Theo, Le, Thi Thuy Hang, Dong, Thi Lan, Huynh, Trong Hieu, Ho, Phien Huong, Le, Nguyen Thanh Thao, Truong, Cong Thao, Pham, Hoang Phi, Luong, Cong Y., Y, Nie Lim, Cao, Minh Ngoc, Nguyen, Duy Khanh, Le, Thi Thanh, Vuong, Duc Cuong, Nguyen, Le Khanh Hang, Do, Minh Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685539/
https://www.ncbi.nlm.nih.gov/pubmed/34938290
http://dx.doi.org/10.3389/fimmu.2021.766112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685539/
https://www.ncbi.nlm.nih.gov/pubmed/34938290
http://dx.doi.org/10.3389/fimmu.2021.766112

Ejemplares similares